APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 44 filers reported holding APTOSE BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $14,741 | -96.3% | 25,415 | -96.1% | 0.01% | -93.8% |
Q3 2022 | $395,000 | -51.4% | 657,364 | -35.8% | 0.10% | -45.5% |
Q2 2022 | $812,000 | -74.5% | 1,024,215 | -56.3% | 0.18% | -71.3% |
Q1 2022 | $3,186,000 | +9.1% | 2,342,694 | +19.4% | 0.62% | +23.0% |
Q4 2021 | $2,920,000 | -5.3% | 1,961,594 | +42.8% | 0.50% | -10.0% |
Q3 2021 | $3,084,000 | +0.0% | 1,373,794 | +45.3% | 0.56% | -6.3% |
Q2 2021 | $3,083,000 | +2041.0% | 945,208 | +3619.1% | 0.60% | +1896.7% |
Q1 2021 | $144,000 | -96.6% | 25,415 | -97.3% | 0.03% | -96.9% |
Q4 2020 | $4,231,000 | +4.2% | 925,153 | +38.7% | 0.96% | -12.8% |
Q3 2020 | $4,062,000 | +9571.4% | 667,004 | +5834.2% | 1.10% | +2592.7% |
Q1 2020 | $42,000 | -96.7% | 11,240 | -95.1% | 0.04% | -85.8% |
Q4 2019 | $1,273,000 | +136.2% | 230,200 | -17.0% | 0.29% | +122.3% |
Q3 2019 | $539,000 | -5.8% | 277,200 | +28.3% | 0.13% | -12.2% |
Q2 2019 | $572,000 | – | 216,100 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |